← All organizations
Highest phase reached
Phase 4
First clinical trial
Nov 1, 2012Last known activity
Oct 20, 2017
Timeline
No events for the selected filters.
Drugs by trial phase (9 distinct, 3 trials)
Phase 4 (6 own, 0 via acquisition)
Other trials (1 own, 0 via acquisition)
Indications
Recent trials (8)
- NCT05042024Lead sponsorPhase 3Oct 20, 2017
- NCT05042024Overall official - principal investigatorPhase 3Oct 20, 2017
- NCT05042024Reponsible party - principal investigatorPhase 3Oct 20, 2017
- NCT05506371Lead sponsorN/ASep 16, 2017
- NCT05506371Overall official - principal investigatorN/ASep 16, 2017
- NCT05506371Reponsible party - principal investigatorN/ASep 16, 2017
- NCT03011775Lead sponsorPhase 4Nov 1, 2012
- NCT03011775Reponsible party - principal investigatorPhase 4Nov 1, 2012
Details
- Last known activity
- Oct 20, 2017